Cullinan Oncology Inc
NASDAQ:CGEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Universal Starch Chem Allied Ltd
BSE:524408
|
IN |
|
Nanovibronix Inc
NASDAQ:NAOV
|
US |
|
Gruma SAB de CV
BMV:GRUMAB
|
MX |
|
A
|
Asiro Inc
TSE:7378
|
JP |
|
Huntington Bancshares Inc
NASDAQ:HBAN
|
US |
|
CyberPower Systems Inc
TWSE:3617
|
TW |
|
Magna Mining Inc
XTSX:NICU
|
CA |
During the last 3 months Cullinan Oncology Inc insiders have not bought any shares, and sold 1m USD worth of shares. The stock price has increased by 39% over this period (open performance analysis).
The last transaction was made on
Mar 5, 2026
by
Michaelson Jennifer
, who
sold
125.4k USD
worth of 
CGEM shares.
During the last 3 months Cullinan Oncology Inc insiders have not bought any shares, and sold 1m USD worth of shares. The stock price has increased by 39% over this period (open performance analysis).
The last transaction was made on
Mar 5, 2026
by
Michaelson Jennifer
, who
sold
125.4k USD
worth of CGEM shares.
Cullinan Oncology Inc
Glance View
Cullinan Oncology, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company is headquartered in Cambridge, Massachusetts and currently employs 31 full-time employees. The company went IPO on 2021-01-08. The firm is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The Company’s lead candidate, CLN-081 in a Phase I/IIa, is an orally available small molecule designed as an irreversible epidermal growth factor receptor (EGFR), inhibitor that is designed to selectively target cells expressing mutant EGFR variants, including EGFR exon 20 insertion (EGFRex20ins), mutations, with relative sparing of cells expressing wild type EGFR. The Company’s evaluating CLN-081 as a treatment for non-small cell lung cancer (NSCLC), in adult patients with EGFRex20ins mutations in a Phase I/IIa trial. The Company’s other product candidates include CLN-049, CLN-619, CLN-617, CLN-978, Opal and Jade.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
